Other Events ·
Clinuvel Pharmaceuticals Limited announced that its American Depositary Shares (ADS) commenced trading on the Nasdaq…
CLVLYClinuvel Pharmaceuticals Ltd
Clinuvel Pharmaceuticals Limited announced that its American Depositary Shares (ADS) commenced trading on the Nasdaq Stock Market on July 20, 2026, under the ticker symbol CUVL. This transition marks the company's uplift from a Level I American Depositary Receipt (ADR: CLVLY) to a Level II program. The company is listed on both the Australian Securities Exchange (ASX: CUV) and the Nasdaq. Clinuvel Pharmaceuticals Limited is a biopharmaceutical company focused on developing therapies for genetic, metabolic, and dermatological disorders.